Sridharan Gururangan Selected Research

Sridharan Gururangan Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 01/2002
34	Glioma (Gliomas) 01/2022 - 01/2002
24	Brain Neoplasms (Brain Tumor) 10/2021 - 01/2002
21	Medulloblastoma 11/2021 - 01/2002
15	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 12/2005
4	Pinealoma (Pineoblastoma) 01/2020 - 06/2003
4	Ependymoma 01/2016 - 01/2002
4	Hypoxia (Hypoxemia) 01/2014 - 12/2010
4	Astrocytoma (Pilocytic Astrocytoma) 08/2013 - 01/2002
2	Diffuse Intrinsic Pontine Glioma 01/2022 - 01/2022
2	Neutropenia 01/2021 - 01/2002
2	Headache (Headaches) 08/2017 - 03/2006
2	Mucositis 08/2017 - 12/2010
2	Exanthema (Rash) 08/2017 - 12/2010
2	Neoplasm Metastasis (Metastasis) 01/2016 - 11/2013
2	Primitive Neuroectodermal Tumors (PNET) 08/2014 - 04/2010
2	Hearing Loss (Hearing Impairment) 06/2014 - 04/2014
2	Ototoxicity 04/2014 - 08/2008
2	Hydrocephalus (Hydrocephaly) 02/2009 - 11/2008
2	Disease Progression 07/2002 - 01/2002
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2022
1	Leukopenia 01/2021
1	Polyneuropathies (Polyneuropathy) 05/2019
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 05/2019
1	Edema (Dropsy) 12/2017
1	Nausea 12/2017
1	Infratentorial Neoplasms (Posterior Fossa Tumors) 12/2017
1	Hamartoma 08/2017
1	Tuberous Sclerosis (Bourneville's Disease) 08/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2016
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 10/2015

Drug/Important Bio-Agent (IBA)

17	Bevacizumab (Avastin)FDA Link 01/2019 - 02/2007
17	Irinotecan (Camptosar)FDA LinkGeneric 01/2014 - 01/2002
11	Temozolomide (Temodar)FDA LinkGeneric 06/2011 - 02/2003
7	O(6)-benzylguanineIBA 10/2009 - 05/2002
6	Biological ProductsIBA 01/2021 - 08/2014
6	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 12/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 11/2008
5	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2012 - 12/2005
5	Tyrosine Kinase InhibitorsIBA 12/2011 - 09/2005
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014 - 05/2009
4	Monoclonal AntibodiesIBA 04/2011 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2008
3	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 08/2008
3	Carboplatin (JM8)FDA LinkGeneric 03/2012 - 07/2002
3	ErbB Receptors (EGF Receptor)IBA 12/2010 - 02/2006
3	Topoisomerase I InhibitorsIBA 10/2005 - 04/2004
3	Carmustine (FIVB)FDA Link 04/2004 - 05/2002
2	dipinacoline glutamateIBA 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021 - 08/2017
2	AZD 6244IBA 10/2021 - 08/2017
2	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2014
2	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2015
2	Vincristine (Oncovin)FDA LinkGeneric 05/2019 - 08/2008
2	ParaffinIBA 01/2016 - 11/2013
2	Formaldehyde (Formol)FDA Link 01/2016 - 11/2013
2	3- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA 08/2015 - 09/2011
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2015 - 09/2011
2	Amifostine (Ethyol)FDA LinkGeneric 06/2014 - 08/2008
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2013 - 12/2004
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2010 - 01/2010
2	Sirolimus (Rapamycin)FDA Link 01/2010 - 02/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2010 - 02/2006
2	TOR Serine-Threonine KinasesIBA 01/2010 - 02/2006
2	laromustine (VNP40101M)IBA 09/2008 - 02/2008
2	Alkylating AgentsIBA 09/2008 - 02/2008
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 05/2007 - 12/2005
2	Adenosine Triphosphate (ATP)IBA 05/2007 - 12/2005
1	Cell-Free Nucleic AcidsIBA 11/2021
1	Protons (Proton)IBA 07/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	tyrosyltyrosine (Tyr-Tyr)IBA 01/2021
1	Retinoblastoma ProteinIBA 01/2021
1	palbociclibIBA 01/2021
1	Vinca AlkaloidsIBA 05/2019
1	1-(carboxymethylthio)tetradecaneIBA 05/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2017
1	Everolimus FDA Link 08/2017
1	Amylases FDA Link 08/2017
1	Lipase (Acid Lipase)FDA Link 08/2017
1	Retinaldehyde (Retinal)IBA 08/2017
1	Mitogen-Activated Protein KinasesIBA 08/2017
1	A 17 (A-17)IBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2015
1	3' Untranslated Regions (3' UTR)IBA 10/2015

Therapy/Procedure

21	Therapeutics 07/2021 - 01/2002
13	Drug Therapy (Chemotherapy) 05/2019 - 01/2002
6	Radiotherapy 01/2016 - 01/2002
5	Craniospinal Irradiation 07/2021 - 08/2008
4	Salvage Therapy 11/2008 - 04/2006
3	Hearing Aids (Hearing Aid) 06/2014 - 08/2008
2	Immunotherapy 11/2021 - 10/2015
2	Proton Therapy 07/2021 - 07/2021
2	Chemoradiotherapy 01/2016 - 01/2011
2	Aftercare (After-Treatment) 09/2015 - 08/2008
2	Radioimmunotherapy 01/2006 - 09/2005
1	Craniotomy 12/2017
1	Cytoreduction Surgical Procedures 01/2016
1	Induction Chemotherapy 10/2015